Uterine disorders Flashcards
fibroids epidemiology
incidence 20-40%
most common benign tumour in women
pathophysiology of fibroids
benign smooth muscle tumour arising from myometrium
intramural most common
submucosal
subserosal
growth stimulated by oestrogen
risk factors for developing fibroids
obesity early menarche increasing age FH african-american
history of fibroids
pressure symptoms +/- abdominal distension
urinary frequency or chronic retention
heavy menstrual bleeding
subfertility
acute pelvic pain (rare), rapidly growing fibroid undergoes necrosis and haemorrhage. rarely, pedunculated fibroids can undergo torsion
examination of fibroids
solid mass or enlarged uterus may be palpable on abdominal or bimanual examination
uterus is usually non-tender
DD for uterine fibroids
endometrial polyp
ovarian tumours
leiomyosarcoma
adenomyosis
investigations in fibroids
pelvic ultrasound
MRI: rarely required, unless sarcoma is suspected
medical managment of fibroids
tranexamic or mefanemic acid
hormonal contraceptives
GnRH analogues
selective progesterone receptor modulators
hormonal contraceptives for fibroids
Useful to control menorrhagia
Includes the COCP, POP and Mirena IUS
GnRH analogues
Zolidex
fibroid management
Suppresses ovulation, inducing a temporary menopausal state.
Useful pre-operatively to reduce fibroid size and lower complications.
Can be used for 6 months only, due to the risk of osteoporosis
Selective progesterone receptor modulators in fibroids
fibroid management
Ulipristal/ esyma
Reduces size of fibroid and menorrhagia
Useful pre-operatively or as an alternative to surgery
Use of Ulipristal is restricted due to risk of severe liver injury
surgical management of fibroids
hysteroscopy and transcervical resection of fibroid
myomectomy
uterine artery embolization
hysterectomy
presentation of fibroids
Asymptomatic
Heavy menstrual bleeding (menorrhagia) is the most frequent presenting symptom
Prolonged menstruation, lasting more than 7 days
Abdominal pain, worse during menstruation
Bloating or feeling full in the abdomen
Urinary or bowel symptoms due to pelvic pressure or fullness
Deep dyspareunia (pain during intercourse)
Reduced fertility
initial investigation in submucosal fibroids presenting with heavy menstrual bleeding
hysteroscopy
initial investigation for larger fibroids
pelvic USS
<3cm fibroid medical mx
Mirena coil (1st line) – fibroids must be less than 3cm with no distortion of the uterus
Symptomatic management with NSAIDs and tranexamic acid
Combined oral contraceptive
Cyclical oral progestogens
<3cm fibroid surgical mx
Endometrial ablation
Resection of submucosal fibroids during hysteroscopy
Hysterectomy
> 3cm fibroid medical mx
gynae referral
Symptomatic management with NSAIDs and tranexamic acid
Mirena coil – depending on the size and shape of the fibroids and uterus
Combined oral contraceptive
Cyclical oral progestogens
> 3cm fibroid surgical mx
Uterine artery embolisation
Myomectomy
Hysterectomy
GnRH agonists for fibroids
GnRH agonists, such as goserelin (Zoladex) or leuprorelin (Prostap), may be used to reduce the size of fibroids before surgery.
They work by inducing a menopause-like state and reducing the amount of oestrogen maintaining the fibroid.
Usually, GnRH agonists are only used short term, for example, to shrink a fibroid before myomectomy.
uterine artery embolization for fibroids
Uterine artery embolisation is a surgical option for larger fibroids, performed by interventional radiologists.
The radiologist inserts a catheter into an artery, usually the femoral artery.
This catheter is passed through to the uterine artery under X-ray guidance.
Once in the correct place, particles are injected that cause a blockage in the arterial supply to the fibroid.
This starves the fibroid of oxygen and causes it to shrink.
myomectomy surgical mx for fibroids
Myomectomy involves surgically removing the fibroid via laparoscopic (keyhole) surgery or laparotomy (open surgery).
Myomectomy is the only treatment known to potentially improve fertility in patients with fibroids.